Company Filing History:

3 out of 10

Smithkline Beecham (Cork) Ltd

patents

2 out of 6

Sb Pharmco Puerto Rico Inc.

Smithkline Beechman Cork Limited

patent

Years Active: 2009-2012

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8158645 - Compound, corresponding compositions, preparation and/or treatment methods (2012-04-17),

2. 7902378 - Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment (2011-03-08),

3. 7893100 - Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment (2011-02-22),

4. 7759384 - Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment (2010-07-20),

5. 7754733 - Crystalline topotecan hydrochloride product and process for making the same (2010-07-13),

6. 7750036 - Carvedilol salts, corresponding compositions, methods of delivery and/or treatment (2010-07-06),

7. 7649010 - Carvedilol hydrobromide (2010-01-19),

8. 7626041 - Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment (2009-12-01),

Title: The Innovations of Philip C Dell'Orco

Introduction

Philip C Dell'Orco is a notable inventor based in King of Prussia, PA (US). He holds a total of 8 patents, showcasing his significant contributions to the field of pharmaceutical sciences. His work primarily focuses on novel compounds and methods for treating various diseases, including cancer and hypertension.

Latest Patents

Dell'Orco's latest patents include a groundbreaking crystalline form of topotecan monohydrochloride pentahydrate. This compound is designed to treat anti-viral and cancer-related diseases. Another significant patent involves carvedilol phosphate salts, which are used to treat hypertension, congestive heart failure, and angina. These inventions highlight his commitment to advancing medical treatments through innovative pharmaceutical compositions.

Career Highlights

Throughout his career, Dell'Orco has worked with prominent companies such as SmithKline Beecham Ltd and Sb Pharmco Puerto Rico Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of medical science.

Collaborations

Dell'Orco has collaborated with notable professionals in his field, including Lee M Katrincic and Christopher S Brook. These partnerships have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Philip C Dell'Orco's contributions to pharmaceutical innovation are significant and noteworthy. His patents reflect a dedication to improving healthcare through advanced treatments. His work continues to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com